Home › Hidradenitis Suppurativa › Georgia
Hidradenitis Suppurativa clinical trials in Georgia
8 studies for Hidradenitis Suppurativa are looking for participants at sites in Georgia.
Cities in Georgia
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Sandy Springs
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Sep 24, 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Cleaver Medical Group Dermatology- Site Number : 8400008, Cumming
- First Georgia Physician Group- Site Number : 8400033, Fayetteville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US102, Cumming
- Investigative Site US051, Marietta
- Investigative Site US103, Sandy Springs
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Lane Dermatology and Dermatologic Surgery, Columbus
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Sep 15, 2026 · NCT07049575Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- Advanced Medical Research - Atlanta- Site Number : 8400011, Atlanta
- Georgia Skin & Cancer Clinic- Site Number : 8400009, Savannah
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07170917Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Advanced Medical Research Pc, Sandy Springs
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Aug 6, 2026 · NCT07213973Myriad™ Augmented Soft Tissue Reconstruction Registry
- Northeast Georgia Medical Center, Inc., Gainesville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT05243966A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
- DelRicht Research, Atlanta
- Southeast Research Specialist LLC, Douglasville
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated May 29, 2026 · NCT07287644From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.